Patent · US Active

PH20 polypeptide variants, formulations and uses thereof

US11041149B2 · kind B2 · utility

20Cited by
85References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 2020
Grant dateJun 22, 2021
Priority date—
Expiry dateMar 19, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.